S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Today Only: Get a 4K Camera Drone for Just $80
The Small Biotech Scaring Big Pharma (Ad)
Estonia to buy US rocket artillery system in $200M deal
Rail workers say deal won't resolve quality-of-life concerns
The Small Biotech Scaring Big Pharma (Ad)
Russia rejects $60-a-barrel cap on its oil, warns of cutoffs
Thousands protest in South Korea in support of truckers
The Small Biotech Scaring Big Pharma (Ad)
Ukraine urges tougher Western squeeze on Russian oil prices
UK arrests wealthy Russian as police target Putin enablers
S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Today Only: Get a 4K Camera Drone for Just $80
The Small Biotech Scaring Big Pharma (Ad)
Estonia to buy US rocket artillery system in $200M deal
Rail workers say deal won't resolve quality-of-life concerns
The Small Biotech Scaring Big Pharma (Ad)
Russia rejects $60-a-barrel cap on its oil, warns of cutoffs
Thousands protest in South Korea in support of truckers
The Small Biotech Scaring Big Pharma (Ad)
Ukraine urges tougher Western squeeze on Russian oil prices
UK arrests wealthy Russian as police target Putin enablers
S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Today Only: Get a 4K Camera Drone for Just $80
The Small Biotech Scaring Big Pharma (Ad)
Estonia to buy US rocket artillery system in $200M deal
Rail workers say deal won't resolve quality-of-life concerns
The Small Biotech Scaring Big Pharma (Ad)
Russia rejects $60-a-barrel cap on its oil, warns of cutoffs
Thousands protest in South Korea in support of truckers
The Small Biotech Scaring Big Pharma (Ad)
Ukraine urges tougher Western squeeze on Russian oil prices
UK arrests wealthy Russian as police target Putin enablers
S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Today Only: Get a 4K Camera Drone for Just $80
The Small Biotech Scaring Big Pharma (Ad)
Estonia to buy US rocket artillery system in $200M deal
Rail workers say deal won't resolve quality-of-life concerns
The Small Biotech Scaring Big Pharma (Ad)
Russia rejects $60-a-barrel cap on its oil, warns of cutoffs
Thousands protest in South Korea in support of truckers
The Small Biotech Scaring Big Pharma (Ad)
Ukraine urges tougher Western squeeze on Russian oil prices
UK arrests wealthy Russian as police target Putin enablers
NASDAQ:THRX

Theseus Pharmaceuticals - THRX SEC Filings & 10K Form

$6.52
-0.15 (-2.25%)
(As of 12/2/2022 12:00 AM ET)
Add
Compare
Today's Range
$6.22
$6.88
50-Day Range
$4.92
$8.36
52-Week Range
$4.01
$17.13
Volume
27,302 shs
Average Volume
117,819 shs
Market Capitalization
$252.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.00

Recent Theseus Pharmaceuticals SEC Filings

DateFilerForm TypeView
12/01/2022
3:35 PM
Dahms Bradford D. (Reporting)
Theseus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2022
8:06 AM
Theseus Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/03/2022
6:05 AM
Theseus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/03/2022
6:00 AM
Theseus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/19/2022
6:18 AM
Stein Steven H (Reporting)
Theseus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/19/2022
6:16 AM
Stein Steven H (Reporting)
Theseus Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/19/2022
6:15 AM
Theseus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2022
6:18 AM
Theseus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/11/2022
6:15 AM
Theseus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2022
7:13 PM
Theseus Pharmaceuticals (Issuer)
Yi Kathy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2022
7:12 PM
Dukes Iain D. (Reporting)
Theseus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2022
7:10 PM
GORDON CARL L (Reporting)
Theseus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2022
4:15 PM
Foresite Capital Fund V, L.P. (Reporting)
Foresite Capital Management V, LLC (Reporting)
Foresite Capital Opportunity Fund V, L.P. (Reporting)
Foresite Capital Opportunity Management V, LLC (Reporting)
Tananbaum James B. (Reporting)
Theseus Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/13/2022
3:39 PM
Theseus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/18/2022
3:24 PM
HAYDEN DONALD J JR (Reporting)
Theseus Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/18/2022
3:22 PM
Theseus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2022
6:21 AM
Theseus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/12/2022
6:15 AM
Theseus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2022
3:34 PM
Theseus Pharmaceuticals (Filer)
Form DEFA14A
04/25/2022
3:30 PM
Theseus Pharmaceuticals (Filer)
Form DEF 14A
09/15/2021
3:04 PM
Theseus Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
02/04/2021
11:20 AM
Theseus Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
02/04/2021
10:27 AM
Theseus Pharmaceuticals (Filer)
Form D/A
This page (NASDAQ:THRX) was last updated on 12/4/2022 by MarketBeat.com Staff